| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
139,813 |
125,676 |
$8.04M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
37,466 |
33,719 |
$2.56M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
41,650 |
35,619 |
$2.51M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
26,902 |
24,829 |
$1.15M |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
15,688 |
14,291 |
$417K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,730 |
4,375 |
$362K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
7,701 |
6,886 |
$315K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17,439 |
13,971 |
$239K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,924 |
4,428 |
$175K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14,266 |
12,782 |
$160K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,533 |
3,129 |
$58K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
833 |
704 |
$56K |
| 71046 |
Radiologic examination, chest; 2 views |
2,593 |
2,339 |
$48K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
181 |
165 |
$15K |
| 81001 |
|
3,780 |
3,374 |
$8K |
| 73630 |
|
355 |
277 |
$7K |
| 87634 |
|
94 |
91 |
$6K |
| 87807 |
|
608 |
553 |
$5K |
| 93975 |
|
32 |
27 |
$5K |
| 81003 |
|
2,546 |
2,316 |
$5K |
| 81002 |
|
1,718 |
1,511 |
$4K |
| 71250 |
|
66 |
46 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
215 |
179 |
$3K |
| 76830 |
Ultrasound, transvaginal |
35 |
29 |
$2K |
| 81025 |
|
240 |
213 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
210 |
154 |
$1K |
| 87210 |
|
297 |
266 |
$1K |
| 76536 |
|
16 |
13 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
17 |
15 |
$1K |
| 73610 |
|
73 |
53 |
$984.84 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
302 |
280 |
$666.18 |
| 73562 |
|
13 |
12 |
$365.33 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
16 |
16 |
$315.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
14 |
12 |
$273.64 |
| 36415 |
Collection of venous blood by venipuncture |
47 |
40 |
$259.40 |
| 99201 |
|
14 |
12 |
$242.57 |
| 73110 |
|
16 |
12 |
$230.24 |
| 73130 |
|
19 |
15 |
$194.39 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
21 |
17 |
$124.46 |
| 86308 |
|
16 |
16 |
$78.44 |
| 90686 |
|
67 |
57 |
$47.24 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
103 |
90 |
$15.19 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
134 |
108 |
$7.95 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
44 |
38 |
$6.41 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
181 |
171 |
$1.22 |
| 3077F |
|
1,642 |
1,439 |
$0.00 |
| 3078F |
|
16,990 |
15,274 |
$0.00 |
| 3008F |
|
51,309 |
46,078 |
$0.00 |
| 3074F |
|
22,800 |
20,462 |
$0.00 |
| 3079F |
|
8,290 |
7,367 |
$0.00 |
| 3075F |
|
1,371 |
1,218 |
$0.00 |
| 4010F |
|
277 |
231 |
$0.00 |
| 3044F |
|
529 |
479 |
$0.00 |
| 3080F |
|
577 |
518 |
$0.00 |
| Q0112 |
All potassium hydroxide (koh) preparations |
17 |
12 |
$0.00 |